Anti-TNF for post-operative prevention in Crohn's disease: the detection of anti-drug antibodies at time of surgery is associated with an increased risk of endoscopic recurrence

被引：0
|
作者：
Auzolle, C. [1 ]
Houze, P. [2 ]
Tran-Minh, M. -L. [1 ]
Nancey, S. [3 ]
Buisson, A. [4 ]
Fumery, M. [5 ]
Pariente, B. [6 ]
Djenidi, F. [1 ]
Marteau, P. [7 ]
Bouhnik, Y. [8 ]
Seksik, P. [7 ]
Allez, M. [7 ]
机构：
[1] St Louis Hosp, Dept Gastroenterol, Paris, France
[2] St Louis Hosp, Dept Biochem, Paris, France
[3] Lyon Sud Hosp, Hosp Civils Lyon, Dept Gastroenterol, Pierre Benite, France
[4] CHU Estaing, Dept Gastroenterol, Clermont Ferrand, France
[5] CHU Amiens, Dept Gastroenterol, Amiens, France
[6] Claude Huriez Hosp, Dept Gastroenterol, Lille, France
[7] St Antoine Hosp, Dept Gastroenterol, Paris, France
[8] Beaujon Hosp, Dept Gastroenterol, Clichy, France
来源：
JOURNAL OF CROHNS & COLITIS | 2017年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P420
引用
收藏
页码：S290 / S290
页数：1
相关论文
共 50 条
  • [1] ANTI-TNF FOR POST-OPERATIVE PREVENTION IN CROHN'S DISEASE: THE DETECTION OF ANTI-DRUG ANTIBODIES AT TIME OF SURGERY IS ASSOCIATED WITH AN INCREASED RISK OF ENDOSCOPIC RECURRENCE
    Auzolle, Claire
    Houze, Pascal
    Tran-Minh, My-Linh
    Nancey, Stephane
    Buisson, Anthony
    Fumery, Mathurin
    Pariente, Benjamin
    Djenidi, Faycal
    Marteau, Philippe R.
    Bouhnik, Yoram
    Seksik, Philippe
    Allez, Matthieu
    GASTROENTEROLOGY, 2017, 152 (05) : S393 - S393
  • [2] INCREASED RISK OF ANTI-DRUG ANTIBODIES TO A SECOND ANTI-TNF IN PATIENTS WHO DEVELOPED ANTIBODIES TO THE FIRST ANTI-TNF
    Yanai, Henit A.
    Amir, Shira
    Avni-Biron, Irit
    Perets, Tsachi Tsadok
    Shamir, Raanan
    Dotan, Iris
    Assa, Amit
    GASTROENTEROLOGY, 2020, 158 (06) : S671 - S671
  • [3] Anti-TNF Exposure Is Not Associated With Increased Post-Operative Morbidity or Reoperation Among Crohn's Disease Patients
    Weber, Andrew T.
    Sack, Jonathan
    Ha, Christina Y.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S411 - S412
  • [4] Increased risk of anti-drug antibodies to a second anti-TNF in patients who developed antibodies to the first anti-TNF
    Yanai, H.
    Amir, S.
    Biron, I. Avni
    Perets, T. Tsadok
    Shamir, R.
    Dotan, I.
    Assa, A.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S439 - S439
  • [5] Prevention of post-operative recurrence of Crohn's disease among patients with prior anti-TNFα failure: A retrospective multicenter study
    Le Cosquer, Guillaume
    Altwegg, Romain
    Riviere, Pauline
    Bournet, Barbara
    Boivineau, Lucile
    Poullenot, Florian
    Bozon, Anne
    Buscail, Louis
    Laharie, David
    Gilletta, Cyrielle
    DIGESTIVE AND LIVER DISEASE, 2023, 55 (06) : 727 - 734
  • [6] POST-OPERATIVE PROPHYLAXIS WITH ANTI-TNF IN PATIENTS WITH CROHN'S DISEASE WHO ARE ANTI-TNF EXPERIENCED IS ASSOCIATED WITH HIGHER RATES OF PROPHYLAXIS FAILURE
    Golan, Maya Aharoni
    Ollech, Jacob
    Avni-Biron, Irit
    Broitman, Yelena
    Snir, Yifat
    Banai, Hagar
    Leibovitzh, Haim
    Goren, Idan
    Wasserberg, Nir
    Dotan, Iris
    Yanai, Henit A.
    GASTROENTEROLOGY, 2020, 158 (06) : S417 - S417
  • [7] Post-operative prophylaxis with anti-TNF in patients with Crohn's disease who are anti-TNF experienced is associated with higher rates of prophylaxis failure
    Golan, M. Aharoni
    Ollech, J.
    Biron, I. Avni
    Broitman, Y.
    Snir, Y.
    Eran, H. Banai
    Leibovitzh, H.
    Goren, I.
    Wasserberg, N.
    Dotan, I.
    Yanai, H.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S545 - S545
  • [8] Prior Immunogenicity to Anti-TNF Biologics Is Not Associated with Increased Anti-drug Antibodies to Vedolizumab or Ustekinumab
    Nicholas J. Costable
    Zachary A. Borman
    Jiayi Ji
    Marla C. Dubinsky
    Ryan C. Ungaro
    Digestive Diseases and Sciences, 2022, 67 : 2480 - 2484
  • [9] PRIOR IMMUNOGENICITY TO ANTI-TNF BIOLOGICS IS NOT ASSOCIATED WITH INCREASED ANTI-DRUG ANTIBODIES TO VEDOLIZUMAB OR USTEKINUMAB
    Costable, Nicholas J.
    Borman, Zachary A.
    Phan, Becky L.
    Ji, Jiayi
    Dubinsky, Marla
    Ungaro, Ryan C.
    GASTROENTEROLOGY, 2020, 158 (06) : S468 - S469
  • [10] Prior Immunogenicity to Anti-TNF Biologics Is Not Associated with Increased Anti-drug Antibodies to Vedolizumab or Ustekinumab
    Costable, Nicholas J.
    Borman, Zachary A.
    Ji, Jiayi
    Dubinsky, Marla C.
    Ungaro, Ryan C.
    DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (06) : 2480 - 2484
12345